Table 2.
Demographic and clinical characteristic of rheumatoid arthritis patients with poor and good MTX response.
| Poor MTX response | Good MTX response | p | ||
|---|---|---|---|---|
| Median (range) | Median (range) | |||
| Age | 61 (25–88) | 56 (22–89) | 0.008 | |
| Female/male | 97 (89%)/11 | 45 (90%)/5 | >0.99a | |
| Disease duration (years) | 12 (0–48) | 7.5 (0.5–30) | 0.028 | |
| ESR (mm/h) | 39 (0–160) | 15 (1–86) | <0.0001 | |
| CRP (mg/l) | 19.50 (1.3–89) | 7 (0–104) | <0.0001 | |
| DAS28 | 5.45 (1.99–7.9) | 2.65 (0.97–5.95) | <0.0001 | |
| n (%) | n (%) | OR (95% CI) | pa | |
|---|---|---|---|---|
| Larsen ≥3 | 69 (60%) | 24 (43%) | 2 (1.05–3.71) | 0.049 |
| RF positive | 74 | 46 | 3.3 (1.6–7.05) | 0.002 |
| Anti-CCP positive | 82 | 75 | 1.7 (0.7–4.15) | 0.32 |
aFisher test.